Key Developments: Zimmer Holdings Inc (ZMH.N)

ZMH.N on New York Stock Exchange

114.17USD
26 Dec 2014
Price Change (% chg)

$0.06 (+0.05%)
Prev Close
$114.11
Open
$114.16
Day's High
$115.17
Day's Low
$114.02
Volume
168,725
Avg. Vol
263,875
52-wk High
$116.11
52-wk Low
$90.48

Search Stocks

Latest Key Developments (Source: Significant Developments)

Zimmer Holdings Inc increases Q1 dividend
Thursday, 24 Apr 2014 07:00am EDT 

Zimmer Holdings Inc:Declared Q1 dividend of $0.22 per share, an increase of 10 pct over dividend declared for prior year period.  Full Article

Zimmer Holdings Inc announces 10 pct increase in quarterly dividend for first quarter of 2014
Wednesday, 5 Mar 2014 05:00pm EST 

Zimmer Holdings Inc:Increases quarterly cash dividend of $0.22 per share will be paid on April 25, 2014, to stockholders of record as of the close of business on March 28, 2014.  Full Article

United States Patent and Trademark Office has issued five new patents to Zimmer Holdings Inc
Monday, 24 Feb 2014 04:30pm EST 

Zimmer Holdings Inc:Says United States Patent and Trademark Office has issued five new patents directed to the Subchondroplasty Procedure, the innovative new joint preservation procedure developed by Zimmer Knee Creations.Patent no's as follows U.S. Patent No. 8,551,178, U.S. Patent No. 8,574,303, U.S. Patent No. 8,608,802, U.S. Patent No. 8,617,166 and U.S. Patent No. 8,623,089.These patents broaden the coverage of the first Subchondroplasty Procedure patent issued, U.S. Patent No. 8,062,364, to include new procedure methods, instrument kits, navigation systems, implants and other anatomical sites.  Full Article

Zimmer Holdings Inc issues FY 2014 guidance in line with analysts' estimates
Thursday, 30 Jan 2014 07:31am EST 

Zimmer Holdings Inc:Expects fiscal 2014 revenues to increase between 3.0 pct. and 5.0 pct. on a constant currency basis.Estimates that foreign currency translation will decrease revenues by about 0.5 pct. for fiscal 2014, resulting in reported revenue growth between 2.5 pct. and 4.5 pct.Sees fiscal 2014 diluted earnings per share (EPS) to be in a range of $5.00 to $5.20 on a reported basis and $6.10 to $6.30 on an adjusted basis.Reported net sales of $4.62 bln in fiscal 2013.Fiscal 2014 revenue of $4.81 bln - Thomson Reuters I/B/E/S.Fiscal 2014 EPS of $6.20 - Thomson Reuters I/B/E/S.  Full Article

Zimmer Holdings Inc announces Q4 dividend and new share repurchase program
Monday, 16 Dec 2013 08:00am EST 

Zimmer Holdings Inc:Says a cash dividend of $0.20 per share will be paid on or about Jan. 31, 2014, to stockholders of record as of the close of business on Dec. 27.Says new share repurchase program authorizes purchases of up to $1.0 billion of the Company's common stock with no expiration date.Says after dec 31, 2013, no further purchases will be made under the existing share repurchase program, which authorized purchases through Dec. 31, 2014.  Full Article

Zimmer Holdings Inc Lowers FY 2013 Guidance-Conference Call
Thursday, 24 Oct 2013 07:00am EDT 

Zimmer Holdings Inc reaffirmed its fiscal 2013 constant currency revenue guidance and updated its reported revenue and earnings guidance for 2013. Fiscal 2013 revenues are expected to increase approximately 4.5% on a constant currency basis from fiscal 2012. The Company now estimates that foreign currency translation will decrease revenues between 1.5% and 2.0% for the year, resulting in reported revenue growth between 2.5% and 3.0%. Previously, the Company had estimated foreign currency translation would decrease revenues by approximately 2.0%. The Company now expects fiscal 2013 diluted earnings per share (EPS) to be approximately $4.40 on a reported basis and approximately $5.70 on an adjusted basis. Prior guidance for fiscal 2013 reported and adjusted diluted earnings per share was $4.70 to $4.80 and $5.70 to $5.80, respectively. This updated guidance includes estimated charges for inventory step-up and other inventory and manufacturing related charges, certain claims and special items of $335 million on a pre-tax basis, or approximately $1.30 per diluted share, on an after-tax basis. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenues of $4.60 billion and EPS of $4.74 for fiscal 2013.  Full Article

Zimmer Holdings Inc Announces Quarterly Dividend For Q3 2013
Monday, 9 Sep 2013 08:00am EDT 

Zimmer Holdings Inc announced that its Board of Directors has authorized the payment of a cash dividend to stockholders for the third quarter of 2013. The cash dividend of $0.20 per share will be paid on or about October 25, 2013, to stockholders of record as of the close of business on September 27, 2013.  Full Article

Zimmer Holdings Inc Receives FDA Clearance For Patient Specific Instruments Shoulder
Friday, 23 Aug 2013 10:44am EDT 

Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a world leader in musculoskeletal care, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the ZimmerPatient Specific Instruments (PSI) Shoulder system to complement its Trabecular Metal Reverse Shoulder system for reverse shoulder arthroplasty (RSA) procedures. Zimmer PSI Shoulder utilizes 3D visualization software to allow a surgeon to create a customized surgical plan for each patient, and then provides patient-specific surgical instrument guides to facilitate placement of the implant corresponding to the personalized surgical plan. Zimmer PSI Shoulder has been available to a limited number of surgeons in Europe since May and it will now be made available to shoulder surgeons across the United States.  Full Article

Judge Orders Zimmer Holdings Inc To Pay Stryker Corp $228 Million In Patent Case-Reuters
Thursday, 8 Aug 2013 06:54pm EDT 

Reuters reported that A federal judge ordered Zimmer Holdings Inc to pay Stryker Corp more than $228 million for infringing its surgical irrigation patents, and in doing so tripled a damages award by a jury that found Zimmer's conduct was willful. U.S. District Judge Robert Jonker in Grand Rapids, Michigan, also issued a permanent injunction banning Zimmer from selling infringing products, including from its Pulsavac Plus line. Zimmer said it plans to appeal the decision.  Full Article

Zimmer Holdings Inc Raises FY 2013 Revenue Guidance; Narrows FY 2013 EPS Guidance To A Range In Line With Analysts' Estimates
Thursday, 25 Jul 2013 07:02am EDT 

Zimmer Holdings Inc announced that it updated its fiscal 2013 revenue and EPS guidance. For fiscal 2013, it expects revenues to increase between 4.0% and 5.0% on a constant currency basis from fiscal 2012. Previously, the Company had estimated full-year revenues would increase between 2.5% and 4.5% constant currency. The Company estimates that foreign currency translation will decrease revenues by approximately 2.0% for fiscal 2013, resulting in reported revenue growth between 2.0% and 3.0%. Previously, the Company had estimated foreign currency translation would decrease revenues by approximately 1.5%. The Company now projects fiscal 2013 diluted earnings per share (EPS) to be in a range of $4.70 to $4.80 on a reported basis and $5.70 to $5.80 on an adjusted basis. Prior guidance for full-year 2013 reported and adjusted diluted earnings per share was $5.05 to $5.25 and $5.65 to $5.85, respectively. The Company reported revenue of $4.47 billion in fiscal 2012. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenues of $4.56 billion and EPS of $5.76 for fiscal 2013.  Full Article

U.S. appeals court cuts damages Zimmer must pay Stryker

- A U.S. federal appeals court has slashed the damages that Zimmer Holdings Inc will have to pay Stryker Corp for infringing its patents on a surgical cleaning wand.

Search Stocks